The meeting was called to order, a quorum was confirmed, and the Inspector of Election was appointed. The meeting was adjourned to allow time for Nasdaq to complete its review of the company's initial listing application, with the reconvened meeting scheduled for July 20, 2026.Based on TransCode Th…
AtaiBeckley ATAI is entering a catalyst-heavy period as its lead depression program moves closer to late-stage testing. The stock story is tied less to current revenue scale and more to whether its pipeline can validate new approaches in difficult mental health conditions.That setup gives growth-or…
Tango Therapeutics TNGX is becoming a clearer test of how precision oncology can shape biotech value in 2026. Its story now centers on MTAP-deleted cancers, synthetic lethality and targeted combinations.For investors, the issue is not whether Tango fits the trend. It does. The question is whether v…
PRINCETON, N.J. & ESPOO, Finland--(BUSINESS WIRE)--July 02, 2026--IQM Quantum Computers NASDAQ:IQMX ("IQM", "IQM Quantum Computers" or the "Company"), a global leader in full-stack superconducting quantum computers, today became a publicly traded company following the completion of its business com…
Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio
(14:47 GMT) Cheesecake Factory Price Target Raised to $79.00/Share From $66.00 by B of A Securities
(14:46 GMT) FactSet Research Price Target Raised to $210.00/Share From $205.00 by B of A Securities
Tango Therapeutics TNGX has become one of 2026’s more dramatic biotechnology stories, with shares up 224.3% year to date and 404.1% over the past year.That rally reflects real clinical progress, but it also raises the bar. Tango remains a clinical-stage company with no approved products, no recurri…
Q4 saw sequential and year-over-year sales growth, driven by bedding segment momentum and operational efficiencies. Restructuring and integration initiatives yielded over $20 million in annualized savings, with tariff refunds set to further reduce debt and improve liquidity.Based on Culp, Inc. [CUL…
NORTHAMPTON, MA / ACCESS Newswire / July 2, 2026 / By Ryan Rose<img height="0" src="https://app.accessnewswire.com/api/iframe/1185910/https://www.youtube.com/embed/dNJneHOYPPw" width="0"/></div></div></div><p><i>This blog was co-authored by Jennifer Mulhern, Vice President of AP Program Access, Col…
(14:45 GMT) Elevance Health Price Target Raised to $482.00/Share From $424.00 by Bernstein
Nvidia Corp. (NVDA, Financials) said it has partnered with AI cloud companies to deploy large-scale, multi-tenant AI factories through a revenue-sharing and credit-support model.Under the plan, cloud providers will sell services delivered through Nvidia DSX AI factories, which are designed to produ…
Integrated BioPharma amended its credit arrangements with PNC Bank, extending the maturity of its $4.0 million revolving credit facility to April 14, 2027, and establishing a new $250,000 Convertible Equipment Line of Credit for capital purchases. Concurrently, the company retired its previously ma…
CCC Intelligent Solutions Price Target Maintained With a $9.00/Share by Stifel
Ravi Thanawala was previously chief financial officer of Nike North America from June 2020 to July 2023. "American Eagle Names Ravi Thanawala CFO, Reaffirms 2026 Outlook" published at 4:37 p.m. ET on July 1 omitted the full location in the name.
Tango Therapeutics TNGX is moving into a decisive period as vopimetostat becomes the center of the investment case.The stock story now rests on MTAP-deleted cancers, 2026 clinical updates and the risks that come with a focused clinical-stage pipeline.Why TNGX Centers on PRMT5 BiologyTango uses synt…
IDAHO FALLS, Idaho, July 2, 2026 /PRNewswire/ -- Radnostix, Inc. (OTCQB: INIS) ("Radnostix" or the "Company"), a leader in radioisotope production and nuclear medicine solutions, today announced the successful closing of its acquisition of key assets from Lucerno Dynamics, LLC, including the LARA®…
Vertex Pharmaceuticals VRTX announced that the FDA has approved its one-shot gene therapy, Casgevy (exagamglogene autotemcel), for the treatment of individuals aged two years and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent beta th…
International Business Machines Corporation IBM has jumped 15.4% over the past three months, underperforming the industry’s growth of 127.3%, largely due to macroeconomic challenges and a sudden development in the artificial intelligence (AI) domain that threatens its core legacy businesses. The st…
Netskope NTSK offers a focused view of how cybersecurity demand is changing as enterprises adopt generative artificial intelligence, autonomous agents and cloud-delivered applications.The company is tying AI governance, secure access service edge and data protection into one platform. That combinat…
